Skip to content

Research on Early Recurrence of Locally Advanced Gastric Cancer Based on CT Radiomics Prediction

Research on Early Recurrence of Locally Advanced Gastric Cancer Based on CT Radiomics Prediction

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07683195
Acronym
LAGC
Enrollment
900
Registered
2026-07-06
Start date
2020-01-01
Completion date
2026-08-31
Last updated
2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

Locally Advanced Gastric Cancer, Early Recurrence, CT, Radiomics

Brief summary

This study aims to develop a model for predicting postoperative recurrence in patients with LAGC using artificial intelligence (AI) technology based on preoperative computed tomography (CT) images

Interventions

None listed

Sponsors

Liu Yang
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. pathology diagnosis of LAGC (pT2NxM0-pT4NxM0); 2. radical gastrectomy with D2 lymph node dissection (\>15 lymph nodes); 3. available clinicopathological data; 4. patients underwent contrast-enhanced abdominal CT scans within 4 weeks before surgery.

Exclusion criteria

1. preoperative treatment for LAGC (radiotherapy, chemotherapy, or systemic therapy); 2. previous malignancies; 3. unsatisfactory gastric distention or inability to identify the primary tumor; 4. image artifacts.

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of early recurrence modelsImmediately evaluated after the early recurrence model was builtIn this study, clinical data and contrast-enhanced CT imaging data of 550 patients with locally advanced gastric cancer from our hospital were collected. Machine learning and deep learning algorithms were applied to assess the early recurrence of patients within one year after surgery. The performance of the artificial intelligence model was evaluated from two dimensions: diagnostic accuracy and stability, and quantitative analysis of its performance was conducted using indicators including the area under the curve (AUC) and the precision-recall curve (PR curve).

Countries

China

Contacts

PRINCIPAL_INVESTIGATORGuangyong Zhang

Qianfoshan Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 8, 2026